As of 2026-04-16, the Fair Value of Klingelnberg AG (KLIN.SW) is -1.50 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.40 CHF, the upside of Klingelnberg AG is -114.40%.
With the market price of 10.40 CHF and our fair value calculation, Klingelnberg AG (KLIN.SW) is not a good investment. Investing in KLIN.SW stocks now will result in a potential loss of 114.40%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | -7.29 | -21.68 | 20.75 | 17.20 | 9.99 | 3.80 |
| YoY growth | 71.24% | -197.27% | 195.75% | -17.10% | -41.96% | 2.13% |
| Market Cap (mil) | 91.94 |
| P/E | |
| Forward P/E | 6.70x |
| EPS | -0.33 |
| Avg earnings growth rate | 2.13% |
| TTM earnings | -2.87 |